2022 U.S. Cancer Diagnostics Market Shares-Competitive Analysis of Leading and Emerging Market Players
This new report provides cancer diagnostics market shares.
The report analyzes current and emerging suppliers of cancer diagnostics analyzers and reagents, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
The report analyzes current and emerging suppliers of cancer diagnostics analyzers and reagents, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
COMPANY ASSESSMENTS
The report provides strategic assessments of over 30 leading cancer diagnostics market players and start-up companies with innovative technologies and products, including:
Abbott
Affymetrix
Beckman Coulter/Danaher/Cepheid
Becton Dickinson
bioMerieux
Bio-Rad
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujifilm Wako
Fujirebio
Grifols
Hologic/Gen-Probe
Leica Biosystems/Kreatech
Ortho-Clinical Diagnostics/Carlyle Group
Qiagen
Roche
Siemens Healthineers
Takara Bio
Thermo Fisher and others.
The report provides strategic assessments of over 30 leading cancer diagnostics market players and start-up companies with innovative technologies and products, including:
Abbott
Affymetrix
Beckman Coulter/Danaher/Cepheid
Becton Dickinson
bioMerieux
Bio-Rad
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujifilm Wako
Fujirebio
Grifols
Hologic/Gen-Probe
Leica Biosystems/Kreatech
Ortho-Clinical Diagnostics/Carlyle Group
Qiagen
Roche
Siemens Healthineers
Takara Bio
Thermo Fisher and others.
More Publications
US Endocrine Function Testing Market Supplier Shares and Segment Forecasts 2017-2021: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers
US$ 3,500.00
December 2017
271 pages
2017-2021 US HIV/AIDS Diagnostics Market: Emerging Opportunities and Growth Strategies
US$ 2,070.00
February 2017
250 pages
2020 US Microbiology Market: Supplier Shares and Sales Segment Forecasts
US$ 950.00
March 2020
43 pages
2015-2019 Growth Strategies for the US Hospital Hematology and Flow Cytometry Markets
US$ 5,440.00
July 2015
248 pages
2017 US Home/Self Testing Market Future Horizons and Growth Strategies
US$ 1,305.00
March 2017
175 pages
